Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

MHRA green light for DemeRx’s opioid use disorder trial

pharmatimesMarch 11, 2021

Tag: MHRA , DemeRx , ibogaine HCl , atai Life Sciences , opioid

PharmaSources Customer Service